Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 5, 2002, Pages 1192-1202

  Koukourakis, Michael I ^a,c   Giatromanolaki, Alexandra ^a   Sivridis, Efthimios ^a   Simopoulos, Constantinos ^a   Turley, Helen ^b   Talks, Kate ^b   Gatter, Kevin C ^b   Harris, Adrian L ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c Tumor and Angiogenesis Research Group Alexandroupolis   (Greece)

Author keywords

Angiogenesis; Head and neck cancer; Hypoxia inducible factors; Radiotherapy

Indexed keywords

BIOPSY; GENES; METABOLISM; PATIENT MONITORING; PROTEINS; TUMORS;

CHEMORADIOTHERAPY;

RADIOTHERAPY;

CARBOPLATIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; ASSOCIATION; CANCER PATIENT; CANCER SURVIVAL; CELL NUCLEUS; CHILD; CONTROLLED STUDY; CYTOPLASM; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MICROVASCULATURE; MUCOSA; NECK MUSCLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; RELAPSE; SAMPLE; SKULL; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

ANOXIA; ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0036680153     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02848-1     Document Type: Article

References (38)

1. Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes
2. Isoenzyme specific regulation of genes involved in energy metabolism by hypoxia: Similarities with the regulation of erythropoietin
3. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells
4. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
5. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1a
6. Oxygen distribution in squamous cell carcinoma metastases and its relationship in outcome of radiation therapy
7. Oxygenation predicts radiation response and survival in patients with cervix cancer
8. Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions
9. Angiogenesis: Prognostic significance in laryngeal cancer
10. Angiogenesis vs. response after combined chemo-radiotherapy of squamous cell head and neck cancer
11. High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy
12. Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: Independence from tumour radiosensitivity
13. Angiogenesis, thymidine phosphorylase and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy
14. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages
15. Vascular endothelial growth factor as a marker of tumor endothelium
16. VEGF/KDR activated microvessel density (aMVD) vs. CD31 standard microvessel density (sMVD) in non-small cell lung cancer
17. Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation
18. Expression and subcellular localisation of human AP endonuclease 1 (HAP1/Ref-1) protein: A basis for its role in human disease
19. Nonparametric estimation from incomplete observations
20. Evaluation of survival data and two new rank order statistics arising in its consideration
21. Regression models and life-tables
22. Overexpression of hypoxia-inducible factor 1a in common human cancers and their metastases
23. Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression
24. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
25. The influence of oxygen-tension and pH on the expression of platelet-derived endothelial cell growth factor thymidine phosphorylase in human breast-tumor cells grown in vitro and in vivo
26. Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumors and survival
27. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
28. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit
29. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor
30. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
31. Expression of hypoxia-inducible factor-1alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer
32. Nuclear expression of human apuriniv/apyrimidinic endonouclease (HAP1/Ref-1) in head and neck cancer is associated with resistance to chemo-radiotherapy and poor outcome
33. Squamous cell head and neck cancer: Angiogenic regeneration during radiotherapy?
34. Blackade of the vascular endothelial growth factor stress response increases the antitumor effect of ionizing radiation
35. Induction of thymidine phosphorylase activity and enhancement of Capecitabine efficacy by Taxol/Taxotere in human cancer xenografts
36. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia
37. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia
38. UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response